Newsletter
Trial of colloids vs crystalloids for hypovolemic shock, testosterone and CV mortality, review of malignant gliomas, and more.

JAMA Editor’s Summary

Trial of colloids vs crystalloids for hypovolemic shock, testosterone and CV mortality, review of malignant gliomas, and more.

Editor's Audio Summary by Mary McGrae McDermott, MD, Senior Editor, the Journal of the American Medical Association, for the November 06, 2013 issue
November 5, 2013

Trial of colloids vs crystalloids for hypovolemic shock, testosterone and CV mortality, review of malignant gliomas, and more.

Editor’s Audio Summary by Mary McGrae McDermott, MD, Senior Editor, the Journal of the American Medical Association, for the November 06, 2013 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Preventing Blindness with Early Mobile Eye Disease Detection Spect CEO discusses eye disease screenings for early diagnosis and treatment.